# GlenmarkPharma

Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Corporate Social Responsibility](https://glenmarkpharma.com/corporate-social-responsibility/)
- [Portfolio](https://glenmarkpharma.com/portfolio/)
- [Pipeline](https://glenmarkpharma.com/pipeline/)
- [Adverse Events Reporting](https://glenmarkpharma.com/adverse-events-reporting/)
- [Home Test](https://glenmarkpharma.com/home-test/)

## Press Release
- [Glenmark Pharmaceuticals Inc\., USA launches Methylene Blue Injection USP, 50 mg/10 mL \(5 mg/mL\) Single\-Dose Vial](https://glenmarkpharma.com/press_release/glenmark-pharmaceuticals-inc-usa-launches-methylene-blue-injection-usp-50-mg-10-ml-5-mg-ml-single-dose-vial/)
- [Glenmark Launches Winlevi® \(clascoterone\) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris](https://glenmarkpharma.com/press_release/glenmark-launches-winlevi-clascoterone-10-mg-g-cream-in-key-european-markets-for-the-treatment-of-acne-vulgaris/)
- [Glenmark Pharmaceuticals Inc\., USA launches Lacosamide Injection USP, 200 mg/20 mL \(10 mg/mL\), Single\-Dose Vials](https://glenmarkpharma.com/press_release/glenmark-pharmaceuticals-inc-usa-launches-lacosamide-injection-usp-200-mg-20-ml-10-mg-ml-single-dose-vials/)
- [Glenmark Pharmaceuticals Announces Q4 \& FY26 Financial Results](https://glenmarkpharma.com/press_release/glenmark-pharmaceuticals-announces-q4-fy26-financial-results/)
- [Glenmark Pharmaceuticals Inc\., USA Launches Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial](https://glenmarkpharma.com/press_release/glenmark-pharmaceuticals-inc-usa-launches-vancomycin-hydrochloride-for-injection-usp-500-mg-vial-and-1-g-vial/)

## Quarterly Results
- [Press Release Q4 FY26](https://glenmarkpharma.com/quarterly_results/press-release-q4-fy26/)
- [Earnings Call Transcript Q4 FY26](https://glenmarkpharma.com/quarterly_results/earnings-call-transcript-q4-fy26/)
- [Earnings Call Recording Q4 FY26](https://glenmarkpharma.com/quarterly_results/earnings-call-recording-q4-fy26/)
- [MDA Q4 FY26](https://glenmarkpharma.com/quarterly_results/mda-q4-fy26/)
- [Audited financial results Q4 FY26](https://glenmarkpharma.com/quarterly_results/audited-financial-results-q4-fy26/)

## Annual Reports
- [Annual Secretarial Compliance Report 2025 \- 26](https://glenmarkpharma.com/annual_reports/annual-secretarial-compliance-report-2025-26/)
- [Annual Secretarial Compliance Report 2024\-25](https://glenmarkpharma.com/annual_reports/annual-secretarial-compliance-report-2024-25/)
- [AGM Notice 2023\-24](https://glenmarkpharma.com/annual_reports/agm-notice-2023-24/)
- [Annual Report 2023\-24](https://glenmarkpharma.com/annual_reports/annual-report-2023-24/)
- [Annual Returns 2024\-25](https://glenmarkpharma.com/annual_reports/annual-returns-2024-25/)

## Investor Presentations
- [Investor Day 2026](https://glenmarkpharma.com/investorpresentation/investor-day-2026/)
- [Q4 FY26](https://glenmarkpharma.com/investorpresentation/q4-fy26/)
- [Q2 FY25](https://glenmarkpharma.com/investorpresentation/q2-fy25/)
- [Q1 FY22](https://glenmarkpharma.com/investorpresentation/q1-fy22/)
- [Q2 FY22](https://glenmarkpharma.com/investorpresentation/q2-fy22/)

## Other Announcements
- [Disclosure under Regulation 30 of SEBI LODR 2015 \- U\.S\. FDA Inspection](https://glenmarkpharma.com/other_announcements/disclosure-under-regulation-30-of-sebi-lodr-2015-u-s-fda-inspection/)
- [Intimation of Trading Window Closure \(Q1\)](https://glenmarkpharma.com/other_announcements/intimation-of-trading-window-closure-q1/)
- [Newspaper Publications – Q4 FY26 Results](https://glenmarkpharma.com/other_announcements/newspaper-publications-q4-fy26-results/)
- [Transfer Of Company's Nebulizer Brand](https://glenmarkpharma.com/other_announcements/transfer-of-companys-nebulizer-brand-this-is-for-nebulizer-brand_signed/)
- [Change in Management](https://glenmarkpharma.com/other_announcements/change-in-management-this-is-for-se_outcome_signed/)

## Shareholding Patterns
- [Q4](https://glenmarkpharma.com/shareholding_pattern/q4-8/)
- [Q3](https://glenmarkpharma.com/shareholding_pattern/q3-8/)
- [Q2](https://glenmarkpharma.com/shareholding_pattern/q2-8/)
- [Q1](https://glenmarkpharma.com/shareholding_pattern/q1-7/)
- [Q4](https://glenmarkpharma.com/shareholding_pattern/q4-7/)

## Reconciliation of Share Capital Audit Report
- [Q4](https://glenmarkpharma.com/reconciliation_share/q4-8/)
- [Q2](https://glenmarkpharma.com/reconciliation_share/q2-2/)
- [Q3](https://glenmarkpharma.com/reconciliation_share/q3-8/)
- [Q2](https://glenmarkpharma.com/reconciliation_share/q2-8/)
- [Q1](https://glenmarkpharma.com/reconciliation_share/q1-8/)

## Integrated Corporate Governance Report
- [Q4](https://glenmarkpharma.com/integrated_corporate/q4-8/)
- [Q3](https://glenmarkpharma.com/integrated_corporate/q3-8/)
- [Q2](https://glenmarkpharma.com/integrated_corporate/q2-8/)
- [Q1](https://glenmarkpharma.com/integrated_corporate/q1-8/)
- [Q4](https://glenmarkpharma.com/integrated_corporate/q4-7/)

## My Library
- [Footer](https://glenmarkpharma.com/?oceanwp_library=footer)
- [Header](https://glenmarkpharma.com/?oceanwp_library=header)
- [Search](https://glenmarkpharma.com/?oceanwp_library=search)

## Years
- [2025](https://glenmarkpharma.com/years/2025/)
- [2024](https://glenmarkpharma.com/years/2024/)
- [2018](https://glenmarkpharma.com/years/2018/)
- [2019](https://glenmarkpharma.com/years/2019/)
- [2020](https://glenmarkpharma.com/years/2020/)

## months
- [March](https://glenmarkpharma.com/months/03/)
- [February](https://glenmarkpharma.com/months/02/)
- [May](https://glenmarkpharma.com/months/05/)
- [August](https://glenmarkpharma.com/months/08/)
- [November](https://glenmarkpharma.com/months/11/)

## Quarters
- [Q4](https://glenmarkpharma.com/quarter/1/)
- [Q1](https://glenmarkpharma.com/quarter/4/)
- [Q2](https://glenmarkpharma.com/quarter/3/)
- [Q3](https://glenmarkpharma.com/quarter/2/)

## Financial Years
- [2023\-2024](https://glenmarkpharma.com/financial_years/2023-2024/)
- [2022\-2023](https://glenmarkpharma.com/financial_years/2022-2023/)
- [2021\-2022](https://glenmarkpharma.com/financial_years/2021-2022/)
- [2020\-2021](https://glenmarkpharma.com/financial_years/2020-2021/)
- [2024\-2025](https://glenmarkpharma.com/financial_years/2024-2025/)

## Shareholder Years
- [2018\-2019](https://glenmarkpharma.com/shareholder_years/2018-2019/)
- [2019\-2020](https://glenmarkpharma.com/shareholder_years/2019-2020/)
- [2020\-2021](https://glenmarkpharma.com/shareholder_years/2020-2021/)
- [2021\-2022](https://glenmarkpharma.com/shareholder_years/2021-2022/)
- [2022\-2023](https://glenmarkpharma.com/shareholder_years/2022-2023/)

## Reconciliation Years
- [2018\-2019](https://glenmarkpharma.com/reconciliation-years/2018-2019/)
- [2019\-2020](https://glenmarkpharma.com/reconciliation-years/2019-2020/)
- [2020\-2021](https://glenmarkpharma.com/reconciliation-years/2020-2021/)
- [2021\-2022](https://glenmarkpharma.com/reconciliation-years/2021-2022/)
- [2022\-2023](https://glenmarkpharma.com/reconciliation-years/2022-2023/)

## Integrated\_Years
- [2018\-2019](https://glenmarkpharma.com/integrated_years/2018-2019/)
- [2019\-2020](https://glenmarkpharma.com/integrated_years/2019-2020/)
- [2020\-2021](https://glenmarkpharma.com/integrated_years/2020-2021/)
- [2021\-2022](https://glenmarkpharma.com/integrated_years/2021-2022/)
- [2022\-2023](https://glenmarkpharma.com/integrated_years/2022-2023/)

## Investor Presentations Years
- [2025\-2026](https://glenmarkpharma.com/investor-presentations-years/2025-2026/)
- [2024\-2025](https://glenmarkpharma.com/investor-presentations-years/2024-2025/)
- [2023\-2024](https://glenmarkpharma.com/investor-presentations-years/2023-2024/)
- [2022\-2023](https://glenmarkpharma.com/investor-presentations-years/2022-2023/)
- [2021\-2022](https://glenmarkpharma.com/investor-presentations-years/2021-2022/)

## Annual Report Years
- [2024\-2025](https://glenmarkpharma.com/annual_report_years/2024-2025/)
- [2023\-2024](https://glenmarkpharma.com/annual_report_years/2023-2024/)
- [2022\-2023](https://glenmarkpharma.com/annual_report_years/2022-2023/)
- [2021\-2022](https://glenmarkpharma.com/annual_report_years/2021-2022/)
- [2020\-2021](https://glenmarkpharma.com/annual_report_years/2020-2021/)

## Optional
- [Sitemap index](https://glenmarkpharma.com/sitemap_index.xml)